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Chemokineo be shaped by multiple infections over time. Infection with one pathogen can
confer cross-protection against heterologous pathogens. We tested the hypothesis that latent murine
gammaherpesvirus 68 (γHV68) infection modulates host inﬂammatory responses and susceptibility to
mouse adenovirus type 1 (MAV-1). Mice were infected intranasally (i.n.) with γHV68. 21 days later, they were
infected i.n. with MAV-1. We assessed cytokine and chemokine expression by quantitative reverse
transcriptase real-time PCR, cellular inﬂammation by histology, and viral loads by quantitative real-time
PCR. Previous γHV68 infection led to persistently upregulated IFN-γ in lungs and spleen and persistently
upregulated CCL2 and CCL5 in the lungs. Previous γHV68 infection ampliﬁed MAV-1-induced CCL5
upregulation and cellular inﬂammation in the lungs. Previous γHV68 infection was associated with lower
MAV-1 viral loads in the spleen but not the lung. There was no signiﬁcant effect of previous γHV68 on IFN-γ
expression or MAV-1 viral loads when the interval between infections was increased to 44 days. In summary,
previous γHV68 infection modulated lung inﬂammatory responses and decreased susceptibility to a
heterologous virus in an organ- and time-dependent manner.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe herpesviruses are double-stranded DNA viruses that have the
ability to establish lifelong latency in their host. Studies of the
pathogenesis of the human gammaherpesviruses, Epstein–Barr virus
(EBV) and Kaposi's sarcoma-associated herpesvirus, are limited due to
the species-speciﬁcity of the viruses. Murine gammaherpesvirus 68
(γHV68) provides a useful model to study the pathogenesis of a
gammaherpesvirus in its natural host. Similar to its human counter-
parts, γHV68 establishes latency in B lymphocytes, macrophages and
dendritic cells following an initial phase of lytic replication (Flano et
al., 2000; Stewart et al., 1998). In some cases, lung epithelial cells may
also harbor latent virus (Stewart et al., 1998). Viral latency is
maintained by a complicated interplay between host and virus. A
number of γHV68 gene products are involved in active modulation of
host immune responses, including the γHV68 K3 protein, which
downregulates MHC class I (Boname et al., 2004), and the γHV68 M3
protein, which sequesters host chemokine proteins (Parry et al., 2000;
Van Berkel et al., 2000).While both K3 andM3 are lytic genes, they are
also expressed during latent infection (Rochford et al., 2001) and so
may also contribute to the maintenance of latency. γHV68 infectionsearch Building I, 1150 West
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l rights reserved.induces long-term changes in patterns of cytokine expression. We
have reported persistent upregulation of lung CCL5 expression up to
29 days following intranasal (i.n.) γHV68 infection (Weinberg et al.,
2002), and production of tumor necrosis factor (TNF)-α and interferon
(IFN)-γ remains upregulated in the spleen up to at least 41 days post-
infection (d.p.i.) (Barton et al., 2007). It is unclear whether these long-
term alterations in cytokine production are the result of a “resetting”
of baseline host cytokine production following acute γHV68 infection
or if they are the result of ongoing stimulation triggered by
intermittent reactivation of latent virus.
It is also unclear whether viral immunomodulatory functions or
ongoing host immune responses to latent infection affect the
pathogenesis of subsequent infections. The majority of individuals
are infected with EBV during childhood (Rickinson and Kieff, 2001).
Most are also infected with other herpesviruses, such as herpes
simplex virus and cytomegalovirus, that establish persistent infec-
tions. While persistent viruses typically do not cause clinically
signiﬁcant disease in immunocompetent hosts, their presence may
have unrecognized effects on the way in which their hosts respond to
subsequent immunologic stimuli. In a recent report, Barton et al.
demonstrated increased resistance to the intracellular pathogens Lis-
teria monocytogenes and Yersinia pestis, but not to West Nile virus
(WNV), in mice latently infected with γHV68 or with murine
cytomegalovirus (MCMV, Barton et al., 2007). The protection afforded
by latent γHV68 was linked to prolonged IFN-γ production and
macrophage activation following i.n. γHV68 infection (Barton et al.,
2007) and appeared to be a process distinct from previously described
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et al., 2006) or nonspeciﬁc activation of CD8+ memory T cells (Berg et
al., 2003).
Latent γHV68 infection is established following both i.n. and
intraperitoneal (i.p.) infection (Tibbetts et al., 2003). Speciﬁc compar-
isons of long-term changes in cytokine production or other immune
function in speciﬁc compartments (for example, lung and spleen)
following different routes of inoculation have not been performed. It is
possible, however, that these γHV68-induced immunologic changes
differ depending on the route of infection. In the present study, we
investigated whether γHV68 latency was associated with altered
susceptibility to acute respiratory infection with an unrelated virus,
mouse adenovirus type 1 (MAV-1). In addition, we sought to deﬁne
effects on long-term alterations in lung and spleen cytokine and
chemokine expression in the setting of latent γHV68 infection.
Results
Latent γHV68 infection is associated with upregulated lung and spleen
IFN-γ expression
We and others have described pulmonary inﬂammation induced
by acute γHV68 infection (Sarawar et al., 2002; Weinberg et al., 2004;
Weinberg et al., 2002). The expression of a variety of cytokines and
chemokines is upregulated in the lungs following i.n. inoculationwith
γHV68. Protection against bacterial challenge conferred by latent
γHV68 infection is likely to be due at least in part to long-term
changes in cytokine expression, in particular persistent IFN-γ
upregulation, induced by latent γHV68, as measured in the serum
(Barton et al., 2007). We used quantitative reverse transcriptase real-
time PCR (qRT-PCR) to determine whether local lung and spleen
expression of IFN-γ and other cytokines was persistently upregulated
by latent γHV68 infection. Compared to γHV68-naïve mice, baseline
IFN-γ expression prior to MAV-1 infection was signiﬁcantly upregu-
lated in the lungs of γHV68-infected mice at 28 days following
infection (Fig. 1A, 0.99±0.18 fold vs. 15.13±5.59 fold higher than
reference animals mock infected i.p.). IFN-γ expression remained
upregulated in the lungs of γHV68-infected mice at 44 days following
infection, although the magnitude of this effect was less than at
28 days following γHV68 infection (Fig. 1A, 0.45±0.12 fold vs. 6.19±
1.92 fold higher than reference animals). This effect was less
pronounced in the spleens of γHV68-infected mice at 28 d.p.i. (Fig.
1B, 1.62±0.38 fold vs. 7.22±1.84 fold higher than reference animals)
and was absent in spleens at 44 d.p.i. (Fig. 1B).
We assayed other cytokines and chemokines at these time points
in order to determine whether persistent effects of γHV68 infection
were speciﬁc to IFN-γ or were more generalized. CCL2 and CCL5 areFig. 1. Long-term effects of γHV68 infection on cytokine and chemokine expression. Mice w
transcripts in lung (A) and spleen (B) was measured using qRT-PCR. Data were normalized to
mock infected i.p.; dotted line on each graph). For experimental groups, data represent mea
mice at the same time point.chemokines that can be induced by IFN-γ (Casola et al., 2002; Martin
and Dorf, 1991; Pype et al., 1999; Stellato et al., 1995) and that are
upregulated in the lung during both γHV68 (Weinberg et al., 2002)
and MAV-1 (Weinberg et al., 2005) respiratory infection. Both CCL2
and CCL5 remained upregulated in the lungs of γHV68-infected mice
at 28 and 44 d.p.i. compared to γHV68-naïvemice (Fig.1A). The effects
of γHV68 infection on lung CCL2 and CCL5 expression were of a
similar magnitude to the effect on IFN-γ expression and diminished to
a similar degree between 28 and 44 d.p.i. Neither CCL2 nor CCL5 were
upregulated in the spleens of γHV68-infected mice compared to
γHV68-naïve mice at 28 or 44 d.p.i. (Fig. 1B). Lung and spleen
expression of IFN-β was unaffected by γHV68 infection at these time
points (Figs. 1A and B), as were lung and spleen expression of IL-4 and
CXCL1 (data not shown).
Latent γHV68 infection modulates MAV-1-induced lung CCL5 expression
We have previously characterized acute MAV-1 respiratory infec-
tion (Weinberg et al., 2005). Following i.n. infection of mice with 105
plaque-forming units (PFU) MAV-1, peak viral gene expression and
titers of infectious virus are detected at 7 d.p.i. Infectious virus is no
longer detected in the lungs by plaque assay by 14 d.p.i., although
MAV-1 DNA can be detected in the lung by nested PCR and
quantitative real-time PCR (qPCR) up to at least 44 d.p.i. (unpublished
data). Like γHV68, MAV-1 respiratory infection induces the upregula-
tion of multiple chemokines and the inﬂux of immune cells into the
lung (Weinberg et al., 2005). To determine whether latent γHV68
infection modulates host responses to acute MAV-1 respiratory
infection, we inoculated mice i.n. with MAV-1 after the establishment
of γHV68 latency. When MAV-1 infection followed γHV68 infection
by either 28 or 44 days, IFN-γ expression was further induced in the
lung and spleen 7 days after MAV-1 infection (Figs. 2A–D), but there
were no statistically signiﬁcant differences between γHV68-naïve and
γHV68-infected mice in the levels of MAV-1-induced IFN-γ
expression.
MAV-1 infection upregulated lung expression of CCL5 at 7 d.p.i. in
γHV68-naïve mice compared to levels measured before MAV-1
infection. When MAV-1 infection followed γHV68 infection by
28 days, CCL5 upregulation at 7 days post-MAV-1 infection was
signiﬁcantly greater in the lungs of γHV68-infected mice compared to
γHV68-naïve mice (Fig. 3A, compare open and dark bars at 7 days
post-MAV-1 infection). Increased time between γHV68 and MAV-1
infections was associated with dampening, rather than ampliﬁcation,
of lung CCL5 responses induced by MAV-1 (Fig. 3B). When mice were
infected with MAV-1 44 days following γHV68 infection, levels of
CCL5 expression decreased from their already elevated baseline in
γHV68-infected mice at 7 days post-MAV-1 infection.ere mock infected or infected i.n. with 4×104 PFU γHV68. Expression of the indicated
GAPDH expression and are presented as expression relative to a reference group (mice
ns±SEM (n=5 animals per group; ⁎Pb0.05 and ⁎⁎⁎Pb0.001 compared to γHV68-naïve
Fig. 2. Effects ofγHV68 infection onMAV-1-induced lung and spleen IFN-γ expression.Miceweremock infected or infected i.n.with 4×104 PFUγHV68. Allmicewere then infected i.n.
with 105 PFUMAV-1 after 28 days (A, B) or 44 days (C, D). Lung (A,C) and spleen (B,D) IFN-γ expressionwasmeasured using qRT-PCR. Datawere normalized to GAPDH expression and
are presented as expression relative to a reference group (micemock infected i.p.), whose value is set to 1 in each case. For experimental groups, data representmeans±SEM (n=5 to 10
animals per group; ⁎Pb0.05 by Student's t test compared to γHV68-naïve group at the same time point).
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inﬂammation
To determine whether cellular inﬂammatory responses corre-
sponded with chemokine expression in the lung, we evaluated
histological changes in hematoxylin and eosin-stained lung sections.
Lungs from mock-infected mice showed little evidence of cellular
inﬂammation. Lungs of mice infected i.n. with γHV68 had persistent
mononuclear cellular inﬁltrates surrounding airways at 21 d.p.i. (Fig.
4). As we have previously described (Weinberg et al., 2005), acute
MAV-1 respiratory infection in γHV68-naïve mice induced a patchy
mononuclear cell inﬁltrate focused aroundmedium and large airways.
At 7 days post-MAV-1 infection, there was more cellular inﬂammation
in the lungs of γHV68-infected mice compared to γHV68-naïve mice
(Fig. 4). In these mice, dense, nodular collections of mononuclear cells
were observed adjacent to many airways. Latent γHV68 thereforeFig. 3. Effects of γHV68 infection on MAV-1-induced lung CCL5 expression. Mice were mock
28 days (A) or 44 days (B). Lung CCL5 expressionwas measured using qRT-PCR beforeMAV-1
expression and are presented as expression relative to a reference group (mice mock infected
per group; ⁎⁎Pb0.01 and ⁎⁎⁎Pb0.001 by Student's t test compared to γHV68-naïve group aampliﬁed cellular inﬂammation in the lungs of mice subsequently
infected with MAV-1.
MAV-1 viral loads are lower in spleens of γHV68-infected mice
Barton et al. reported that latent γHV68 infection established
following i.n. inoculation confers protection against subsequent i.p.
challenge with L. monocytogenes and either i.n. or subcutaneous
challenge with Y. pestis, but not against footpad inoculationwithWNV
(Barton et al., 2007). To determine whether latent γHV68 decreased
susceptibility to a respiratory viral infection, we challenged mice i.n.
with MAV-1 28 days following i.n. γHV68 infection. We quantiﬁed
MAV-1 viral loads in lungs using qPCR. Previous reports by other
groups (Lenaerts et al., 2006; Lenaerts et al., 2005) use qPCR to
quantify MAV-1 viral loads in a manner similar to that used in our
study. In addition, a recent publication demonstrates good correlationinfected or infected i.n. with γHV68. All mice were then infected i.n. with MAV-1 after
infection and then at 7 days followingMAV-1 infection. Datawere normalized to GAPDH
i.p.), whose value is set to 1 in each case. Data represent means±SEM (n=5 to 10 animals
t the same time point).
Fig. 4. γHV68 ampliﬁes MAV-1-induced lung cellular inﬂammation. Mice were mock infected or infected i.n. with γHV68. All mice were then infected i.n. with MAV-1 after 28 days.
Lungs were harvested beforeMAV-1 infection and then at 7 d.p.i. Hematoxylin and eosin-stained sections were prepared from parafﬁn-embedded sections. Images are representative
of at least 2 animals per condition. Scale bars, 100 μm.
185Y.N. Nguyen et al. / Virology 380 (2008) 182–190between qPCR measurements of γHV68 viral loads and plaque assay
data during acute respiratory infection (Ptaschinski and Rochford,
2008). Although plaque assays may reveal subtle differences in viral
replication missed by qPCR, we relied on qPCR to provide sensitive
and speciﬁc measurements of both MAV-1 and γHV68 DNA and to
avoid the potential confusion of plaques being formed by two different
viruses present in organs of coinfected animals.
At 7 days post-MAV-1 infection, MAV-1 viral loads were not
signiﬁcantly different in the lungs of γHV68-infected mice comparedFig. 5. Effects of γHV68 on MAV-1 viral loads. Mice were mock infected or infected i.n. with γ
MAV-1 viral loads were measured by quantitative real-time PCR in the lungs (A, C) and splee
genome copies of MAV-1 per 100 ng input DNA. Symbols represent values for individual mi
Mann–Whitney rank sum test compare MAV-1 viral loads in γHV68-infected mice to MAV-to γHV68-naïve mice (Fig. 5A). The spleen is another target organ for
MAV-1 following i.n. infection (Kajon et al., 1998). We quantiﬁedMAV-1
viral loads using qPCR to determine whether latent γHV68 affected
levels of MAV-1 in the spleen. Overall, MAV-1 viral loads were lower
in the spleen than in the lung at 7 d.p.i. (compare Y-axes in Figs. 5A
and B). MAV-1 viral loads were signiﬁcantly lower in the spleens of
γHV68-infected mice compared to γHV68-naïve mice (Fig. 5B, 1198±
193 MAV-1 genome copies per 100 ng DNA in γHV68-naïve mice
versus 308±65 in γHV68-infected mice, mean±SEM, Pb0.001). ByHV68. All mice were then infected i.n. with MAV-1 after 28 days (A, B) or 44 days (C, D).
ns (B, D) of coinfected mice at 7 days following MAV-1 infection. Data are expressed as
ce and horizontal bars represent medians for each group. P values calculated using the
1 viral loads in γHV68-naive mice. Any P value not presented was N0.05.
186 Y.N. Nguyen et al. / Virology 380 (2008) 182–190this measure in the spleen, the principal reservoir for latent γHV68,
γHV68-infected mice were therefore less susceptible to subsequent
infectionwith MAV-1. We observed a similar effect, with lower MAV-
1 viral loads in the spleens of γHV68-infected mice compared to
γHV68-naïve mice, when γHV68 was delivered i.p. rather than i.n.
(data not shown).
Latent γHV68 infection confers protection against subsequent
bacterial infection when the bacterial infection occurs up to 3 months
following i.n. γHV68 infection (Barton et al., 2007). To determine
whether the effects of latent γHV68 infection on subsequent MAV-1
infection lasted beyond 28 days, we infected animals i.n. with MAV-1
44 days following γHV68 infection. After this interval between
infections, there were no differences in MAV-1 viral loads at 7 d.p.i.
between γHV68-infected and γHV68-naïve mice in the lungs (Fig. 5C)
or spleen (Fig. 5D). To address the possibility that prior γHV68
infection inﬂuenced MAV-1 viral loads at times later than 7 days post-
MAV-1 infection, we conducted an additional experiment in which
MAV-1 infection followed γHV68 infection by 38 days. There were no
signiﬁcant differences in MAV-1 lung and spleen viral loads between
γHV68-infected and γHV68-naïve mice at 14 days following MAV-1
infection (Supplemental Figure).
Acute MAV-1 infection does not increase γHV68 viral loads
Reactivation from latency is a critical component of the
gammaherpesvirus life cycle. While the molecular events that lead
to gammaherpesvirus reactivation are increasingly understood, the
physiological stimuli that trigger reactivation are not well described.
Inﬂammatory challenges, including intra-abdominal bacterial infec-
tion (Cook et al., 2002) and administration of exogenous TNF-α
(Koffron et al., 1999), have been reported to induce the reactivation
of latent MCMV in vivo. To determine whether acute MAV-1
infection induced reactivation of latent γHV68, we quantiﬁed
γHV68 viral loads in the lungs and spleens of latently infectedFig. 6. AcuteMAV-1 infection does not alter γHV68 viral loads. Mice weremock infected or in
44 days (C, D). γHV68 viral loads were measured using quantitative real-time PCR in lungs
infection. Data are expressed as genome copies of γHV68 per 100 ng input DNA. Symbols repr
values calculated using the Mann–Whitney rank sum test compare γHV68 viral loads beformice that were subsequently infected with MAV-1. We detected
γHV68 DNA in the lungs and spleens of γHV68-infected mice at 28
and 44 d.p.i. (Fig. 6). When MAV-1 infection followed γHV68
infection by 28 days, lung γHV68 viral loads decreased between 0
and 7 days post-MAV-1 infection (Fig. 6A) but spleen viral loads
remained essentially unchanged (Fig. 6B). MAV-1 infection had no
effect on lung or spleen γHV68 viral loads when γHV68 and MAV-1
infections were separated by 44 days (Figs. 6C and D). While it is
likely that low-level γHV68 reactivation in these experiments
escaped detection by the molecular assay we used, our data indicate
that acute MAV-1 infection was not associated with increases in
γHV68 DNA levels.
Prior MAV-1 infection modulates susceptibility to acute γHV68 infection
Latent infection with either γHV68 or MCMV was shown to confer
cross-protection to bacterial pathogens (Barton et al., 2007). Our
results suggest that latent γHV68 conferred resistance to subsequent
MAV-1 infection. To determine whether cross-protection to γHV68
could be established following MAV-1 infection, we infected mice i.n.
with MAV-1. 21 days later, MAV-1-naïve and MAV-1-infected mice
were then infected i.n. with γHV68.We used qRT-PCR tomeasure lung
and spleen IFN-γ expression and qPCR to measure lung and spleen
γHV68 viral loads at 7 days post-γHV68 infection. Lung IFN-γ
expression induced by γHV68 was increased in MAV-infected mice
relative to MAV-1-naïve mice (Fig. 7A), while spleen IFN-γ expression
induced by γHV68 was modestly decreased in MAV-infected mice
relative to MAV-1-naïve mice (Fig. 7B). Increased lung IFN-γ
expression correlated with signiﬁcantly lower γHV68 viral loads in the
lungs ofMAV-1-infectedmice (Fig. 7C, 2071±464γHV68 genome copies
per 100ngDNA inMAV-1-naïvemiceversus 701±182 inMAV-1-infected
mice, mean±SEM, P=0.019). In contrast, prior MAV-1 infection had no
effect on spleen γHV68 viral loads (Fig. 7D). Prior MAV-1 infection was
therefore capable of altering susceptibility to subsequent γHV68fected i.n. with γHV68. All micewere then infected i.n. withMAV-1 after 28 days (A, B) or
(A, C) and spleens (B, D) before MAV-1 infection and then at 7 days following MAV-1
esent values for individual mice and horizontal bars represent medians for each group. P
e and after MAV-1 infection. Any P value not presented was N0.05.
Fig. 7. Effects of prior MAV-1 infection on acute γHV68 infection. Mice were mock infected or infected i.n. with MAV-1. All mice were then infected i.n. with γHV68 after 21 days. Lung
(A) and spleen (B) IFN-γ expression was measured using qRT-PCR. Data was normalized to GAPDH expression and are presented as expression in MAV-1-infected mice relative to
MAV-1-naïve mice, whose value is set to 1. γHV68 viral loads were measured by quantitative real-time PCR in the lungs (C) and spleens (D) of coinfected mice at 7 days following
γHV68 infection. Data are expressed as genome copies of γHV68 per 100 ng input DNA. Symbols represent values for individual mice and horizontal bars represent medians for each
group. P values calculated using the Mann–Whitney rank sum test compare γHV68 viral loads in MAV-1-infected mice to γHV68 viral loads in MAV-1-naïve mice. Any P value not
presented was N0.05.
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γ expression.
Discussion
The immune system depends on a state of memory established
following a primary infection to provide some measure of protection
from subsequent infection with the same pathogen. Accumulating
evidence suggests that cross-protection, in which a primary infection
with one pathogen confers protection from subsequent infectionwith
an unrelated pathogen, can occur in a variety of circumstances and via
several different mechanisms. In this study, we report that prior
γHV68 infection alters responses to subsequent MAV-1 respiratory
infection. Mice previously infectedwith γHV68 had lowerMAV-1 viral
loads in the spleens than did γHV68-naïve mice. We demonstrate that
this effect was organ-speciﬁc, present in spleen but not lung, despite
upregulation of IFN-γ expression in both organs at the time of MAV-1
infection. Both IFN-γ upregulation and the effect of previous γHV68
infection on MAV-1 viral loads diminished with increased time
between γHV68 and MAV-1 infections. The ability to provide cross-
protection was not limited to latent γHV68 infection, because we
observed lower γHV68 viral loads in the lungs during acute γHV68
infection of mice persistently infected with MAV-1 compared to
MAV-1-naïve mice.
Similar to previous work by Barton et al. (2007), we report
persistent upregulation of IFN-γ expression associated with latent
γHV68 infection. Like human adenoviruses, MAV-1 is relatively
resistant to direct effects of IFN-γ in vitro (Kajon and Spindler,
2000). This is likely due to immunomodulatory effects of the MAV-1
E1A gene, because E1A-null MAV-1 mutant viruses are more sensitive
to IFN-γ than wild type MAV-1 (Kajon and Spindler, 2000). IFN-γ
likely plays a role in vivo, however, because mice deﬁcient for IFN-γ
show more extensive MAV-1 replication than wild type mice (K.R.
Spindler, personal communication). We found that local expression of
IFN-γ remained upregulated in the lungs and spleen at time points
after acute γHV68 infection has typically resolved. γHV68-infectedmice had lower spleen MAV-1 viral loads following acute MAV-1
respiratory infection than did γHV68-naïve mice. Despite increased
levels of IFN-γ expression in the lungs of γHV68-infected mice,
however, we observed no differences in lungMAV-1 viral loads. Latent
γHV68 is more abundant in the spleen than in the lungs (Fig. 6), which
may lead to differences in local IFN-γ production stimulated by latent
virus. Organ-speciﬁc differences in the way macrophages or other cell
types respond to upregulated IFN-γ, chemokines or other mediators
stimulated by latent γHV68 may also account for the lack of an effect
of latent γHV68 on MAV-1 viral loads in the lung.
We also assessed lung expression of CCL2 and CCL5, chemokines
that likely contribute to the control of viral infection by recruiting cells
such as monocytes, lymphocytes, NK cells and dendritic cells (Luster,
1998). CCL2 and CCL5 expression is increased in the lungs of infected
mice during acuteMAV-1 respiratory infection (Weinberg et al., 2005),
suggesting that these chemokines or cells they recruit recruited play
roles in the control of acute MAV-1 infection. Similar to our previous
ﬁndings (Weinberg et al., 2002), persistent chemokine upregulation
was present in the lungs at 28 and 44 days following i.n. γHV68
infection. CCL2 and CCL5 production can be induced by IFN-γ (Casola
et al., 2002; Martin and Dorf, 1991; Pype et al., 1999; Stellato et al.,
1995), potentially linking persistent IFN-γ upregulation in the lungs of
γHV68-infected mice to persistent upregulation of these chemokines.
Persistent inﬂammation following γHV68 infection did not seem to be
a universal, nonspeciﬁc phenomenon. We did not observe persistent
upregulation of a type I interferon (IFN-β), a classic Th2-type cytokine
(IL-4), or an additional chemokine (CXCL1), further suggesting that
much of the persistent inﬂammation associated with γHV68 infection
is driven by IFN-γ.
When acute MAV-1 infection followed γHV68 by 28 days,
enhanced immunopathology and greater CCL5 upregulation were
present in the lungs of γHV68-infected mice compared to γHV68-
naïve controls. Chronic stimulation by increased local levels of CCL2,
CCL5, or other mediators not measured in our study may prime
immune cells resident in the lung to respond more exuberantly to
acute MAV-1 infection, leading to even more pronounced cellular
188 Y.N. Nguyen et al. / Virology 380 (2008) 182–190inﬁltrates in the lungs of γHV68-infected mice following MAV-1
infection. Alternatively, CCL5 production by the increased number of
recruited inﬂammatory cells may account for the increased levels of
CCL5.
The cellular inﬁltrates induced by acute MAV-1 infection of
γHV68-infected mice resemble the follicular-like accumulation of
lymphocytes termed bronchus-associated lymphoid tissue, or BALT.
BALT has been described in a number of situations, often in the context
of chronic inﬂammation (Tschernig and Pabst, 2000). Histological
ﬁndings similar to those we report here, including BALT, were
described in association with a variety of viral coinfections, in which
increased BALT was frequently seen in coinfected animals compared
to naïve animals infected with a single virus (Chen et al., 2003). In
some cases, such as acute vaccinia virus (VV) infection of lymphocytic
choriomeningitis virus (LCMV)-, MCMV- or inﬂuenza-immune mice,
increased pulmonary pathology in coinfected animals was associated
with decreased titers of the second pathogen, while in other cases
(acute LCMV or acute MCMV infection of inﬂuenza-immune mice) it
was associated with increased viral titers. Different patterns of
cytokine induction speciﬁc to different viruses may account for
opposite effects on subsequent infection with an unrelated virus.
Alternatively, Chen et al. suggested that increased numbers of
macrophages and lymphocytes recruited by acute LCMV or MCMV
infection in inﬂuenza-immunemice could serve as targets of infection
for LCMV and MCMV, allowing for increased titers of these viruses in
inﬂuenza-immune mice (Chen et al., 2003). A similar effect during
acute MAV-1 infection of γHV68-infected mice could balance out any
cross-protection afforded by latent γHV68 infection, resulting in the
lack of apparent differences in lung viral loads that we report.
Previous viral infection has been shown to alter host responses to
subsequent viral challenges. For instance, mice infected with LCMV
that were then infected with VV demonstrated improved survival,
augmented viral clearance and altered immunopathology compared
to LCMV-naïvemice (Chen et al., 2001). This effect was associatedwith
the accumulation of LCMV-speciﬁc IFN-γ-producing memory CD8+ T
cells following VV challenge. Similar effects on VV pathogenesis by
immunity to MCMV or inﬂuenza A virus were also associated with
enhanced Th1-type cytokine responses induced by VV (Chen et al.,
2003). Latent γHV68 infection conferred protection from subsequent
infection by the bacterial pathogens, L. monocytogenes and Y. pestis,
but not by a viral pathogen, WNV (Barton et al., 2007). In that report,
γHV68-mediated cross-protection also involved increased IFN-γ
production but occurred in a T cell-independent manner. Instead,
the authors showed that peritoneal macrophages were activated and
exhibited increased bactericidal activity in mice latently infected with
γHV68. They suggested that these effects were the result of ongoing
subclinical reactivation of latent γHV68 and chronic stimulation of
IFN-γ.
The generation of cross-protective responses can depend on the
timing between infections. For instance, increased susceptibility to
bacterial infection (L. monocytogenes, Staphylococcus aureus and Sal-
monella typhimurium) was noted when bacterial infection occurred
2 days following LCMV infection (Navarini et al., 2006). When
bacterial infection was delayed until 5 days following LCMV infection
in this study, LCMV-immune mice cleared L. monocytogenes better
than LCMV-naïve controls (Navarini et al., 2006). On the other hand,
Barton et al. demonstrate that the effects of latent γHV68 on
subsequent bacterial infection remain fairly consistent over at least
12 weeks, although the magnitude of the effect was somewhat less at
later time points (Barton et al., 2007). We demonstrate that γHV68-
mediated cross-protection fromMAV-1 became less pronounced over
a relatively short time period. γHV68-mediated effects were different
when mice were challenged with MAV-1 at 28 days versus 44 days
following γHV68 infection. Spleen MAV-1 viral loads were signiﬁ-
cantly lower in γHV68-infected mice when infected with MAV-1 at
28 days, but this effect was absent when MAV-1 infection occurred44 days following γHV68 infection. This may in part relate to the
disappearance of upregulated spleen IFN-γ expression inmice latently
infected with γHV68 (Fig. 2D). The γHV68 inoculum dose that we
used (4×104 PFU) was similar to the dose used by Barton et al. (104
PFU) in their study reporting increased levels of IFN-γ in the serum as
long as 41 days following i.n. γHV68 infection (Barton et al., 2007).
Mouse strain-speciﬁc differences in immune responses to γHV68
between the BALB/cmice used in our study and the C57BL/6mice used
by Barton et al. may account for some of the differences between the
coinfectionmodels. Compared to C57BL/6mice, BALB/cmice exhibited
greater levels of lung IFN-γ production and viral gene expression in
the lungs during acute γHV68 infection (Weinberg et al., 2004). In that
study, however, we did not assess cytokine production at time points
beyond 15 d.p.i. that would correspond to predominantly latent
γHV68 infection. Taken together, our data suggest that it is more likely
a persistent perturbation in host immune function induced by γHV68
infection, rather than latent γHV68 infection per se, that leads to
decreased MAV-1 viral loads in the spleens of γHV68-infected
animals.
An individual's accumulated history of infections is likely to shape
immune responses to subsequent pathogens, with each infection
producing both short- and long-term changes in immune function. In
this report, we expand on the understanding of how γHV68
modulates host immune responses to and control of a second
pathogen, MAV-1. Changes mediated by γHV68 may be beneﬁcial if
they result in accelerated clearance of a pathogen, such as withMAV-1
in the spleens of γHV68-infected mice. This protection may come at
the cost of enhanced immunopathology, such as that seen in the lungs
following MAV-1 infection of γHV68-infected mice. Alterations in
innate and adaptive immunity due to genetic differences engineered
in knockout mice modulate host susceptibility to various pathogens.
An increasing number of genetic differences are being identiﬁed in
humans that result in altered immune responses and susceptibility to
pathogens. Our work and work with other coinfection models
highlight the fact that a history of infections, latent virus or otherwise,
must be considered in addition to host genetic factors regulating
immune responses when considering how a particular host will
respond to an infection.
Materials and methods
Viruses, mice and infections
Wild type γHV68 (WUMS strain, ATCC VR-1465) was grown in owl
monkey kidney cells and titers of viral stocks were determined by
plaque assay on 3T3 cells as previously described (Weinberg et al.,
2002). Wild type MAV-1, kindly provided by Kathy Spindler
(University of Michigan), was grown and passaged in NIH 3T6
ﬁbroblasts, and titers of viral stocks were determined by plaque
assay on 3T6 cells as previously described (Cauthen et al., 2007).
Four- to six-week old male BALB/c mice were purchased from
Harlan and maintained in microisolator cages. Under light anesthesia
with ketamine and xylazine, mice were inoculated either i.p. with
4×104 PFU γHV68 diluted to a total of 100 μl in sterile phosphate-
buffered saline (PBS) or i.n. with 4×104 PFU γHV68 diluted to a total
volume of 40 μl in sterile PBS. Control mice were inoculated i.p. or i.n.
with conditioned media at an equivalent dilution in PBS. Following
infection, mice were returned to their cages and allowed to recover.
Either 28, 38 or 44 days following γHV68 infection, micewere infected
i.n. with 105 PFU MAV-1 under light anesthesia with ketamine and
xylazine. Some mice were euthanized immediately prior to MAV-1
infection and the remainder at 7 days post-MAV-1 infection. Organs
were harvested, snap frozen and stored at −20 °C until processed
further. In some mice, the order of infection was reversed so that they
were initially mock infected or infected i.n. with MAV-1 and then
infected i.n. with γHV68 21 days later. Organs were then harvested at
Table 1
Primers and probes used for real-time PCR analysis
Target Oligonucleotide Sequence (5′ to 3′)
MAV-1 E1A Forward primer GCACTCCATGGCAGGATTCT
Reverse primer GGTCGAAGCAGACGGTTCTTC
Probe TACTGCCACTTCTGC
γHV68 gB Forward primer GGCCCAAATTCAATTTGCCT
Reverse primer CCCTGGACAACTCCTCAAGC
Probe ACAAGCTGACCACCAGCGTCAACAAC
IFN-γ Forward primer AAAGAGATAATCTGGCTCTGC
Reverse primer GCTCTGAGACAATGAACGCT
IFN-β Forward primer AGCTCCAAGAAAGGACGAACAT
Reverse primer GCCCTGTAGGTGAGGTTGATCT
GAPDH Forward primer TGCACCACCAACTGCTTAG
Reverse primer GGATGCAGGGATGATGTTC
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relevant federal and institutional policies.
Histology
In a subset of mice, lungs were harvested and ﬁxed in 10% formalin.
Prior to ﬁxation, lungs were gently inﬂated with PBS via the trachea to
maintain lung architecture. After ﬁxation, organs were embedded in
parafﬁn, and 5 μm sections were cut for histopathology. Sections were
stained with hematoxylin and eosin to evaluate cellular inﬁltrates.
Processed sections were viewed through a Laborlux 12 microscope
(Leitz). Digital images were obtained with an EC3 digital imaging
system (Leica Microsystems) using Leica Acquisition Suite software
(Leica Microsystems). Scale bars were added to images using Leica
Acquisition Suite software. Color balance was adjusted and images
were assembled in Adobe Illustrator CS2 (Adobe Systems); otherwise,
no image manipulation was used.
Isolation of RNA and DNA from organs
The left lung was homogenized with sterile glass beads and 1 ml
TRIzol Reagent (Gibco-BRL) using a Mini Beadbeater (Biospec
Products). The homogenates were incubated at room temperature
for 10 min, and then 200 μl of chloroformwere added to each sample.
Following a 3-minute incubation at room temperature, the tubes were
centrifuged at 12,000×g for 15 min at 4 °C. The aqueous phase was
transferred to a new microcentrifuge tube, and total RNA was
precipitated with isopropanol. DNA was extracted from lung and
spleen using the DNeasy® Tissue Kit (Quiagen Inc.) according to the
manufacturer's protocol.
Measurement of viral load
γHV68 and MAV-1 viral loads were measured in organs using
qPCR. γHV68 and MAV-1 viral loads were determined in separate
reactions using primers and probe to detect a 70 bp region of the
γHV68 gB gene or a 59 bp region of the MAV-1 E1A gene (Table 1). 5 μl
of extracted DNA were added to reactions containing TaqMan
Universal PCR Mix (Applied Biosystems), forward and reverse primers
(each at 300 nM ﬁnal concentration for γHV68 gB, 200 nM ﬁnal
concentration for MAV-1 E1A) and probe (200 nM ﬁnal concentration
for γHV68 gB and MAV-1 E1A) in a 25 μl total reaction volume. qPCR
analysis on an ABI Prism 7300 machine (Applied Biosystems)
consisted of 40 cycles of 15 s at 90 °C and 60 s at 60 °C. Standard
curves generated using known amounts of plasmid containing the
γHV68 gB gene of the MAV-1 E1A gene were used to convert cycle
threshold values for experimental samples to copy numbers of γHV68
gB DNA or MAV-1 E1A DNA, respectively. Copy numbers were
standardized to the amount of input DNA and were expressed as
copies of viral genome per 100 ng DNA. Triplicate measurements for
each virus were made for each sample.Analysis of cytokine and chemokine gene expression
Cytokine gene expression was quantiﬁed in RNA extracted from
organs using qRT-PCR. 2.5 μg of RNA was reverse transcribed using
MMLV reverse transcriptase (Invitrogen) according to the manufac-
turer's instructions. The resultant cDNA was ampliﬁed using gene
expression assays for murine CCL2, CCL5, CXCL1, IL-4 and GAPDH
(Applied Biosystems). 2 μl of cDNAwere added to reactions containing
TaqMan Universal PCR Mix and 1.25 μl each of 20×gene expression
assay mix for a target cytokine and GAPDH in a 25 μl total reaction
volume. The murine IFN-γ gene expression assay from Applied
Biosystems did not reliably detect IFN-γ expression in BALB/c mice,
although it did detect expression in C57BL/6mice (data not shown). To
detect murine IFN-γ in BALB/c mice, we used primers shown in Table
1. 2 μl of cDNA were added to reactions containing TaqMan Power
SYBR Green PCR Mix and forward and reverse primers (each primer at
200 nM ﬁnal concentration) in a 25 μl total reaction volume. A
separate reaction was prepared with GAPDH primers (Table 1, each
primer at 200 nM ﬁnal concentration) for each sample. Murine IFN-β
was detected in an identical manner using the primers shown in Table
1. qRT-PCR analysis consisted of 40 cycles of 15 s at 90 °C and 60 s at
60 °C. Melt curve analyses were performed for reactions using SYBR
green. Quantiﬁcation of target gene expression was normalized to
GAPDH and expressed as fold change from control groups using the
comparative CT method (Fink et al., 1998).
Statistical analysis
Data were analyzed for statistical signiﬁcance using Microsoft
Excel or Prism 3 for Macintosh (GraphPad Software Incorporated). For
chemokine and cytokine expression data, differences between groups
were analyzed using Student's t test. For viral load data, differences
between groups were analyzed using the Mann–Whitney rank sum
test. P values less than 0.05 were considered statistically signiﬁcant.
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